Nishadil
Signup Signin
Delhi | 25°C (windy)
Unveiling a Hidden Link: Common Acne Drug Minocycline and Schizophrenia Risk

Unveiling a Hidden Link: Common Acne Drug Minocycline and Schizophrenia Risk
Wockhardt's Game-Changer: India's First Homegrown NCE Accepted by USFDA – A New Dawn?

Wockhardt's Game-Changer: India's First Homegrown NCE Accepted by USFDA – A New Dawn?
A New Chapter for Wockhardt? Chairman 'Very Confident' on Novel Antibiotic's USFDA Acceptance

A New Chapter for Wockhardt? Chairman 'Very Confident' on Novel Antibiotic's USFDA Acceptance
The Superbug Slayer We've Been Waiting For? A Remarkable New Antibiotic Emerges

The Superbug Slayer We've Been Waiting For? A Remarkable New Antibiotic Emerges
Urgent Health Alert: Abbott Warns of Dangerous Counterfeit Amoxyclav Batches Circulating in India

Urgent Health Alert: Abbott Warns of Dangerous Counterfeit Amoxyclav Batches Circulating in India
India's New Weapon Against Superbugs: Wockhardt's Zaynich Offers Hope in Global AMR Crisis

India's New Weapon Against Superbugs: Wockhardt's Zaynich Offers Hope in Global AMR Crisis
Wockhardt Seeks USFDA Nod for Revolutionary Antibiotic Zaynich: A New Hope Against Superbugs

Wockhardt Seeks USFDA Nod for Revolutionary Antibiotic Zaynich: A New Hope Against Superbugs
MicrobiotiX Secures Landmark KRW 20 Billion Series B Funding, Catalyzing Korea's First-Ever Bacteriophage Clinical Trial to Combat Superbugs

MicrobiotiX Secures Landmark KRW 20 Billion Series B Funding, Catalyzing Korea's First-Ever Bacteriophage Clinical Trial to Combat Superbugs
Load more..